Divi's Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review

Date: September 26, 2017
Pages: 39
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: DD34A1A89C1EN
Leaflet:

Download PDF Leaflet

Divi's Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review
Divi's Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Divi's Laboratories Ltd (Divi’s) is a pharmaceutical company which manufactures a broad range Active Pharmaceutical Ingredients (APIs) and intermediates. The product portfolio of the company includes generic APIs, nutraceuticals, custom synthesis of APIs, intermediates and specialty ingredients. The company operates across several countries in Europe and America. It operates manufacturing and research and development units in Hyderabad and Visakhapatnam, India. Divi’s is headquartered in Hyderabad, Telangana, India.

Divi's Laboratories Ltd Key Recent Developments

Sep 20,2017: Divi's Laboratories: Update on USFDA for Unit-II at Visakhapatnam
Jul 22,2017: Divi’s Labs earns a total income of Rs. 851 crores for Q1 of FY18
Jul 22,2017: Divi's Laboratories: Outcome of Board meeting - Appointment of Director
Jul 10,2017: Divi's Laboratories: Update on Unit-II at Visakhapatnam
Mar 22,2017: Divis Laboratories Provides an Update on FDA Import Alert

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Divi's Laboratories Ltd - Key Facts
Divi's Laboratories Ltd - Key Employees
Divi's Laboratories Ltd - Key Employee Biographies
Divi's Laboratories Ltd - Major Products and Services
Divi's Laboratories Ltd - History
Divi's Laboratories Ltd - Company Statement
Divi's Laboratories Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Divi's Laboratories Ltd - Business Description
Divi's Laboratories Ltd - Corporate Strategy
Divi's Laboratories Ltd - SWOT Analysis
SWOT Analysis - Overview
Divi's Laboratories Ltd - Strengths
Divi's Laboratories Ltd - Weaknesses
Divi's Laboratories Ltd - Opportunities
Divi's Laboratories Ltd - Threats
Divi's Laboratories Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 20, 2017: Divi's Laboratories: Update on USFDA for Unit-II at Visakhapatnam
Jul 22, 2017: Divi's Laboratories : Outcome of Board meeting - Appointment of Director
Jul 22, 2017: Divi’s Labs earns a total income of Rs. 851 crores for Q1 of FY18
Jul 10, 2017: Divi's Laboratories: Update on Unit-II at Visakhapatnam
Mar 22, 2017: Divis Laboratories Provides an Update on FDA Import Alert
Jan 09, 2017: Divi's Laboratories Provides Update On It's Unit-II at Visakhapatnam
Dec 07, 2016: Divis Laboratories:US-FDA Inspection of Unit -II at Visakhapatnam
Feb 19, 2016: Divis Laboratories: Inspection of Unit -2 by US-FDA
Feb 05, 2016: DIVI’S laboratories reports third quarter financial results for 2016

SECTION 5 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Divi's Laboratories Ltd, Key Facts
Divi's Laboratories Ltd, Key Employees
Divi's Laboratories Ltd, Key Employee Biographies
Divi's Laboratories Ltd, Major Products and Services
Divi's Laboratories Ltd, History
Divi's Laboratories Ltd, Subsidiaries
Divi's Laboratories Ltd, Key Competitors
Divi's Laboratories Ltd, Ratios based on current share price
Divi's Laboratories Ltd, Annual Ratios
Divi's Laboratories Ltd, Annual Ratios (Cont.1)
Divi's Laboratories Ltd, Annual Ratios (Cont.2)
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Divi's Laboratories Ltd, Performance Chart (2013 - 2017)
Divi's Laboratories Ltd, Ratio Charts

COMPANIES MENTIONED

Piramal Enterprises Ltd
Jubilant Life Sciences Ltd
Hikal Ltd
Granules India Ltd
Dishman Pharmaceuticals and Chemicals Ltd
Biocon Ltd
Skip to top


Ask Your Question

Divi's Laboratories Ltd (DIVISLAB) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: